Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis C Leppert

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Fertility and Sterility|October 12, 2004
Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometriumPhyllis C Leppert, Thomas Baginski, Cara Prupas, et al.
Plos One|April 30, 2019
Evidence of biomechanical and collagen heterogeneity in uterine fibroidsFriederike L Jayes, Betty Liu, Liping Feng, et al.
Current Protein & Peptide Science|March 23, 2016
Biochemical Pathways and Myometrial Cell Differentiation Leading to Nodule Formation Containing Collagen and FibronectinLiping Feng, Friederike L Jayes, Lauren N C Johnson, et al.
Biology of Reproduction|November 21, 2014
Dynamic reciprocity between cells and their microenvironment in reproductionJeffrey T Thorne, Thalia R Segal, Sydney Chang, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|August 25, 2009
Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomasJohn M Norian, Minnie Malik, Candace Y Parker, et al.
Fertility and Sterility|August 12, 2003
Strategy for elucidating differentially expressed genes in leiomyomata identified by microarray technologyWilliam H Catherino, Cara Prupas, John C M Tsibris, et al.
Genes, Chromosomes & Cancer|May 13, 2004
Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloidsWilliam H Catherino, Phyllis C Leppert, Matthew H Stenmark, et al.
Journal of Women'S Health (2002)|March 14, 2009
Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysisMegan E B Clowse, Millie A Behera, Carey K Anders, et al.
Clinical and Translational Medicine|July 29, 2021
Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroidsMd Soriful Islam, Sadia Afrin, Bhuchitra Singh, et al.
Fertility and Sterility|July 29, 2011
Comparing focused ultrasound and uterine artery embolization for uterine fibroids-rationale and design of the Fibroid Interventions: reducing symptoms today and tomorrow (FIRSTT) trialEsther V A Bouwsma, Gina K Hesley, David A Woodrum, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Fertility and Sterility|October 12, 2004
Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometriumPhyllis C Leppert, Thomas Baginski, Cara Prupas, et al.
Plos One|April 30, 2019
Evidence of biomechanical and collagen heterogeneity in uterine fibroidsFriederike L Jayes, Betty Liu, Liping Feng, et al.
Current Protein & Peptide Science|March 23, 2016
Biochemical Pathways and Myometrial Cell Differentiation Leading to Nodule Formation Containing Collagen and FibronectinLiping Feng, Friederike L Jayes, Lauren N C Johnson, et al.
Biology of Reproduction|November 21, 2014
Dynamic reciprocity between cells and their microenvironment in reproductionJeffrey T Thorne, Thalia R Segal, Sydney Chang, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|August 25, 2009
Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomasJohn M Norian, Minnie Malik, Candace Y Parker, et al.
Fertility and Sterility|August 12, 2003
Strategy for elucidating differentially expressed genes in leiomyomata identified by microarray technologyWilliam H Catherino, Cara Prupas, John C M Tsibris, et al.
Genes, Chromosomes & Cancer|May 13, 2004
Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloidsWilliam H Catherino, Phyllis C Leppert, Matthew H Stenmark, et al.
Journal of Women'S Health (2002)|March 14, 2009
Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysisMegan E B Clowse, Millie A Behera, Carey K Anders, et al.
Clinical and Translational Medicine|July 29, 2021
Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroidsMd Soriful Islam, Sadia Afrin, Bhuchitra Singh, et al.
Fertility and Sterility|July 29, 2011
Comparing focused ultrasound and uterine artery embolization for uterine fibroids-rationale and design of the Fibroid Interventions: reducing symptoms today and tomorrow (FIRSTT) trialEsther V A Bouwsma, Gina K Hesley, David A Woodrum, et al.
Pageof 5